APA (7th ed.) Citation

Machado, M. A. d. A., Gandhi-Banga, S., Gallo, S., Cousseau, T. G., Byrareddy, R. M., Nissilä, M., . . . Monfredo, C. (2024). Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza season. Human vaccines & immunotherapeutics, 20(1), 2322196. https://doi.org/10.1080/21645515.2024.2322196

Chicago Style (17th ed.) Citation

Machado, Marina Amaral de Avila, Sonja Gandhi-Banga, Sophie Gallo, Tathyana Giannotti Cousseau, Reddappa Maniganahally Byrareddy, Markku Nissilä, Jörg Schelling, and Celine Monfredo. "Enhanced Passive Safety Surveillance of High-dose and Standard-dose Quadrivalent Inactivated Split-virion Influenza Vaccines in Germany and Finland During the 2022/23 Influenza Season." Human Vaccines & Immunotherapeutics 20, no. 1 (2024): 2322196. https://doi.org/10.1080/21645515.2024.2322196.

MLA (9th ed.) Citation

Machado, Marina Amaral de Avila, et al. "Enhanced Passive Safety Surveillance of High-dose and Standard-dose Quadrivalent Inactivated Split-virion Influenza Vaccines in Germany and Finland During the 2022/23 Influenza Season." Human Vaccines & Immunotherapeutics, vol. 20, no. 1, 2024, p. 2322196, https://doi.org/10.1080/21645515.2024.2322196.